Work with thought leaders and academic experts in Cellular and Molecular Neuroscience

Dr. Everson A Nunes is a highly accomplished researcher and educator in the field of physiological sciences. He received his Ph.D. in Cellular and Molecular Biology with a focus on Physiological Sciences from Universidade Federal do Paraná in 2009, after completing a BSc in Human Nutrition and an MSc in Physiological Sciences. He also holds a specialization in Exercise Physiology and a BSc in Biological Sciences from Universidade Federal do Paraná. Dr. Nunes has a strong background in research, having completed two post-doctoral fellowships at McMaster University and Universidade Federal do Paraná. He has also held positions as an associate professor and assistant professor at Universidade Federal de Santa Catarina. He has published numerous articles in peer-reviewed journals, and his research focuses on the effects of exercise and nutrition on physiological processes in the human body. In addition to his research, Dr. Nunes is also a dedicated educator. He has taught at various universities in Brazil, including Universidade Federal de Santa Catarina, Universidade Gama Filho, Faculdades Integradas Espírita, Pontificia Universidade Católica do Paraná, and Faculdade do Litoral Sul. He is known for his dynamic teaching style and his ability to engage students in complex physiological concepts. Dr. Nunes is a member of several professional organizations, including the American Society for Nutrition, the Canadian Society of Exercise Physiology, the Canadian Nutrition Society and the Brazilian Society of Physiology. He is also a regular speaker at national and international conferences, sharing his expertise and research findings with colleagues and students. Overall, Dr. Nunes is a highly qualified and experienced professional in physiological sciences, metabolism, cancer and nutrition. His dedication to research and education makes him a valuable asset to any institution.

Yseult Héjja-Brichard received her PhD in Neuroscience, Cognition, and Behaviour from Université Paul-Sabatier Toulouse, France in 2020. She subsequently completed her first postdoctoral training at the Centre for functional and evolutionary ecology (CNRS) in Montpellier, France. She is now working as a postdoctoral research associate at the University of Maryland, Baltimore County. Yseult Héjja-Brichard’s research interests lie at the intersection of cognitive neuroscience and behavioural ecology. Her work has primarily focused on understanding how the brain efficiently processes information to enable decisions and behaviours. She informs those processes using an evolutionary and ecological perspective.

David J. Hamilton, PhD Neuroscience, GMU, 2016. His current research focus is Efficient Generative AI leveraging biologically plausible computational circuits and spiking neural networks to implement transformer-based algorithms. Dr. Hamilton has extensive R&D experience in Generative AI and Machine Learning capability development. Specific projects include transformer-based LLM sensor parameter tuning, analytic prediction, Cyber Threat Analysis Platform R&D, US Treasury cyber defense, credit card fraud detection, sensor fusion/analysis, LIDAR signal characterization, and active/passive sonar signal detection/classification. Companies for which David has worked include Intelligent Mission Consulting Services (2020-2023), Northrop Grumman (2004-2020), NeuralTech/CardSystems (1994-2004), Raytheon (1980-1994), and AAI (1977-1980). Earlier in his career, David received his MSEE (1981) from Loyola University, Maryland, and his BSEE (1977) from PSU. He is well published, holds memberships in Society for Neuroscience (SfN), AAAS, IEEE, and continues to maintain his association with GMU as an Affiliate Faculty.

Dr. David Siderovski is a renowned scientist and academic, with a career spanning over two decades. He received his Ph.D. in Medical Biophysics from the University of Toronto in 1997, where he specialized in signal transduction and cellular signaling pathways. After completing his doctorate, Dr. Siderovski held various faculty positions at prestigious universities, including the University of North Carolina at Chapel Hill, West Virginia University School of Medicine, and the University of North Texas Health Science Center. At these institutions, Dr. Siderovski has made significant contributions to the field of pharmacology through his research on G protein-coupled receptors (GPCRs) and RGS proteins, which are key regulators of GPCR cellular signaling. His work has helped to advance the understanding of RGS proteins and their roles in various diseases, including cancer, cardiovascular disorders, and neurological disorders. In addition to his research, Dr. Siderovski is also a dedicated educator and mentor. He has taught and mentored numerous undergraduate, graduate, and medical students, and has served as a mentor for postdoctoral fellows and junior faculty members. He is known for his passion and enthusiasm for science and his ability to inspire and guide the next generation of scientists. Dr. Siderovski has received numerous awards and honors for his contributions to the scientific community. He was the recipient of the Abel Award in 2004 from the American Society of Pharmacology & Experimental Therapeutics for his pioneering discoveries of the RGS proteins and the GoLoco motif. He has also served on editorial boards of several scientific journals (including a decade at *J.Biol.Chem.*) and has been a member of various scientific committees, NIH study section panels, and pharma/biotech advisory boards, including for Inspire, Wyeth, and BellBrook Labs. Overall, Dr. David Siderovski is a highly accomplished and respected scientist and educator, whose research has had a significant impact on the field of pharmacology. His dedication and passion for science continue to inspire and influence the next generation of researchers in this field.

Regan Hamel has an MPhil and PhD in Clinical Neurosciences from University of Cambridge. She also has a Bachelor of Science in Neurosciences from McGill University. Her PhD with Stefano Pluchino and John Marioni focused on single cell transcriptomics in the context of neuroinflammation. Since 2021 she has worked as a Bioinformatics scientist at Mogrify Ltd, applying a multitude of computational biology techniques (including single cell omics, bulk RNAseq, and predictive modelling) in the context of cell reprogramming

My work has focused on how we can use data to support decisions to individualize monitoring to optimize human performance.  My work has demonstrated that a one size fits all approach is not the way to optimize performance in any setting.  My monitoring approach is one that utilizes a network physiology paradigm, which focuses on nonlinear dynamic interactions. In my athlete monitoring I focus on leveraging EMA and wearables; biological sampling and resistance exercise and conditioning prescribed to elicit a specific biological response.    Additionally, as a practitioner it is important to understand the limitations of athlete monitoring, which is another area research and practice has focused.  This is an important skillset that is currently being utilized by the in a project entitled “Integrating mHealth and Physical Function to Develop a Predictors of Injury and Optimal Performance Model in Special Military Operators “with the Rangers in the 3/75 Ranger Battalion.  This approach is one that quantifies factors such as dosage variables of training and lifestyle factors (sleep, nutrition, life stress).  Using this data, we are working on individualizing acute training sessions to optimize readiness and performance enhancement.   During my time at Syracuse University, I was the professor of record to teach the NSCA CSCS preparation course and lead the strength and conditioning program.  We were developing a master’s in exercise science and I was in the process of working on certification with the NSCA.  We also worked closely with athletics to secure strength and conditioning assistantships to allow for student funding.  I am currently on several NSCA committees, which include the Education and Women’s Committee (next certification cycle).    I am particularly adept at all phases of the athletic performance enhancement and these experiences have given me expertise in evidence based program design, linear and non-linear periodization, exercise endocrinology, resistance exercise physiology and acute and chronic training readiness and non-training parameters

Joshua Babalola  completed his doctoral studies recently during which he investigated the combinational effects of Type 2 diabetes and protein post translational modification in the pathophysiology of Alzheimer's disease. <br> Joshua is interested in translating life science skills into solving real life problems relating to microbial infections, aging, metabolic dysfunctions and neurodegenerative diseases. Aside these, he advocates for inclusive science and lifestyle changes. Joshua's educational background includes an MSc in Medical Microbiology from Hallym University, South Korea and a PhD in Human Medicine from Medical University of Graz, Austria. He also holds a BSc in Microbiology from Ekiti State University, Nigeria. In Joshua's leisure, he communicates science relating to healthy lifestyle modifications and Dementia via his social media handles.

Following pre-doctoral studies in Mathematics and Theoretical Physics, I received a PhD in Computational Neuroscience from the University of Electro-Communications, Japan in 2009. From 2009, I was a Postdoctoral Researcher in RIKEN BSI. In 2010, I won the prestigious Australian Research Council (ARC) Australian Postdoctoral Award (APD) fellowship, based at the University of Adelaide from 2010–2014. In 2012 he completed a Graduate Certificate in Education (Higher Education) (GCEHE) from the University of Adelaide. From 2014–2017 he was an adjunct research fellow at the University of South Australia. From 2016–2018, he was a Cascade (Marie Curie) Research Fellow in Mathematical Sciences at the University of Nottingham. From 2018- a research fellow at the University of Oslo. His research interests include AI, Artificial and spiking neural networks and learning algorithms, synaptic plasticity, neuronal dynamics, and neuromorphic engineering. Dr. Iannella is a member of SFN and a Senior member of the IEEE.

Biomedical scientist with Ph.D. in Neuroscience. Expertise in neuroscience, molecular biology, neurodegeneration, and fluorescence microscopy. Experienced researcher, problem-solver, and medical writer.

Susan Song, MD/PhD, is a highly accomplished neuroscientist, with extensive education and experience in the field. She received her MD/PhD in Neurology and Neuroscience from Southern Medical University in 2015, where she conducted groundbreaking research on the molecular mechanisms of neurodegenerative diseases. Following this, she completed a post-doctoral fellowship in Neuroscience at the University of Pittsburgh, where she continued to excel in her research and received numerous awards and grants for her work. Dr. Song's expertise lies in studying the underlying causes and potential treatments for various neurological diseases, such as ischemic stroke, traumatic brain injury, glioblastoma, Alzheimer's disease, and multiple sclerosis. She has a deep understanding of the brain and nervous system, and is constantly seeking new ways to unravel the complexities of these diseases. Dr. Song has held several prestigious positions throughout her career, including her current position as Research Assistant Professor at the University of Pittsburgh. She has published numerous articles in top scientific journals and presented her research at international conferences. Her findings have contributed greatly to the field of neurology and have the potential to improve the lives of millions of people suffering from neurological disorders. Overall, Dr. Song is a highly respected and accomplished physician-scientist who is making significant contributions to the field of neurology. With her extensive education, diverse experience, and unwavering dedication to her patients, she is a true leader in the field and a valuable asset to the medical community.